Although the three other reported patients with NUTM1 fusion thyroid carcinomas experienced prolonged survival, of the two cases with sufficient details to evaluate, the patients had histologically and/or immunophenotypically typical NUT carcinoma, and moreover, all three were significantly younger than our patient. This evidence concerns the gene NUTM1 and thyroid gland carcinoma.